DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wyles D, Poordad F, Wang S. et al.
Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial.
Hepatology
2017
DOI: 10.1002/hep.29541.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.